Oxford Endovascular is a spin-off from Oxford University, developing innovative technology to prevent brain hemorrhages. Our flagship product, OxiFlow™️, is a novel, next-generation flow-diverter made from nitinol that accurately diverts blood flow away from aneurysms at risk of rupture. Unlike comp...See more
Headquarters:
United Kingdom of Great Britain and Northern Ireland
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2015 (11 years)
Address:
OXFORD SCIENCE PARK; OXFORD, GB
LOW
spending power
